> Details

Grundmann, David; Goßling, Alina; Schmidt, Lennard; Voigtlaender, Lisa; Ludwig, Sebastian; Linder, Matthias; Waldschmidt, Lara; Demal, Till; Bhadra, Oliver D.; Schaefer, Andreas; Reichenspurner, Hermann; Blankenberg, Stefan; Conradi, Lenard; Westermann, Dirk; Seiffert, Moritz; Schofer, Niklas

Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI
  • Contributor: Grundmann, David; Goßling, Alina; Schmidt, Lennard; Voigtlaender, Lisa; Ludwig, Sebastian; Linder, Matthias; Waldschmidt, Lara; Demal, Till; Bhadra, Oliver D.; Schaefer, Andreas; Reichenspurner, Hermann; Blankenberg, Stefan; Conradi, Lenard; Westermann, Dirk; Seiffert, Moritz; Schofer, Niklas
  • Published: Springer Science and Business Media LLC, 2023
  • Published in: Clinical Research in Cardiology, 112 (2023) 5, Seite 667-676
  • Language: English
  • DOI: 10.1007/s00392-023-02154-y
  • ISSN: 1861-0684; 1861-0692
  • Keywords: Cardiology and Cardiovascular Medicine ; General Medicine
  • Origination:
  • Footnote:
  • Description: Abstract Background Ejection time (ET), acceleration time (AT) and time between left ventricular and aortic systolic pressure peaks (T-LVAo) might be of diagnostic and prognostic use in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). Aim We aimed to assess the diagnostic value and prognostic impact of invasively measured ET, AT, and T-LVAo in patients undergoing TAVI. Methods A total of 1274 patients received invasive measurement of ET, AT and T-LVAo prior to TAVI. Anatomic AS severity was assessed by CT-derived aortic valve calcification density (AVCd). Impact on all-cause mortality was retrospectively analyzed. Results In multivariable linear regression, T-LVAo showed the strongest correlation with AVCd. No prognostic impact of T-LVAo was found according to uni- and multivariable analyses. In contrast, using an individual C-statistic derived cutoff (CD), patients with ET or AT ≥ CD showed lower mortality rates compared to patients with ET or AT < CD (1-year mortality: ET ≥ vs. < CD: 15.01vs. 33.1%, AT ≥ vs < CD 16.3 vs. 26.5%, p < 0.001). Moreover, multivariable analysis identified ET ≥ CD (HR 0.61 [95% CI 0.43–0.87; p < 0.007]) to be associated with beneficial outcome after TAVI, independent from clinical risk factors and echocardiography-derived parameters. Conclusion Among the studied hemodynamic parameters T-LVAo provides the highest diagnostic value, whereas ET is an outcome predictor beyond clinical risk factors and echocardiographic parameters in AS patients following TAVI. These parameters could be of considerable use in diagnostic evaluation and risk assessment of patients scheduled for TAVI. Graphical abstract T-LVAo (yellow): defined as time between left ventricular and aortic systolic pressure peaks. ET (green): Ejection Time defined as time from the start to flow end. AT (orange): Acceleration time defined as time from the start to the peak flow. AOP: aortic pressure, AVC: aortic valve calcification, CI: confidence interval, HGAS: high-gradient aortic stenosis, LGAS: low-gradient aortic stenosis, LVP: left ventricular pressure, SD: standard deviation.